← FDA Drug Approvals (Drugs@FDA)
HYDROXYZINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-06-11
Drug application
- FDA Application #
ANDA220271- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HYDROXYZINE HYDROCHLORIDE
- Generic name
- HYDROXYZINE HYDROCHLORIDE
- Active ingredients
- HYDROXYZINE HYDROCHLORIDE
- Dosage form
- SYRUP
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- Saptalis Pharmaceuticals, LLC.
- First approval
- 2026-06-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown